• Home
  • Tag: 上海千花网RO

Related Pan Am v Ryanair flying back in time i

first_img RelatedPan Am v Ryanair: flying back in time… infographicPan Am v Ryanair: flying back in time… infographicTop 10 family holidays: best destinations for summer funFor mums and dads, the balmy days of summer often mean daunting weeks to fill with something to keep the wee ones entertained. Never fear: we’ve complied a list of the ten best destinations for guaranteed family fun this year. Enjoy!Flying High | GroundedLiquids and gels not to be stolen from us by security – (hooray!) Click to see the full size infographic – or grab the code at the bottom to embed on your own site! Grab the Embed Codewines of the world Via cheap flights specialists – Skyscanner.net | Grab the code to embed this on your siteReturnOne wayMulti-cityFromAdd nearby airports ToAdd nearby airportsDepart14/08/2019Return21/08/2019Cabin Class & Travellers1 adult, EconomyDirect flights onlySearch flights Maplast_img read more

Miniguts grown from colon cancers spark new treatment hopes

first_imgDespite their out-of-control growth in cancer patients, most tumors don’t survive in lab dishes long enough for doctors or researchers to effectively study them. Now, a team has taken cancerous intestinal tissue from people and grown miniature human guts that retain properties of the original tumors, an advance that may help identify better, or more personalized, treatments for colon cancer.Several years ago, Hans Clevers of the Hubrecht Institute in Utrecht, the Netherlands, and colleagues developed a way to grow intestinal stem cells into miniature organoids of gut tissue in the lab. With a combination of growth factors and gellike media, the researchers can coax the cells to form cell clusters roughly 0.1 mm in diameter with a hollow center and the signature folded crypts that make up the lining of the gut. The organoids can be kept alive in the lab for years, and they can also survive freezing and thawing.Now, with colleagues from the Wellcome Trust Sanger Institute in Hinxton, U.K., and the Broad Institute in Cambridge, Massachusetts, the Dutch team has adapted the technique to cancer. The researchers grew mini-guts from tissue taken from tumor samples from 27 colorectal cancer patients. The technique is surprisingly efficient, growing organoids from up to 90% of patient samples, the team reports today in Cell. To see how well the mini-guts resembled the tumors, the researchers sequenced the genomes of the organoids. Although the match wasn’t perfect, the mini-guts had most of the same cancer-causing mutations found in the original tumor sample. Tumors are often composed of several kinds of cells carrying different sets of mutations. And depending on which part of the tumor a sample came from, an organoid may not include all the cell types present in the patient. Nevertheless, “they capture most if not all of the most important mutations,” says Eduard Batlle at the Institute for Research in Biomedicine in Barcelona, Spain.The technique has advantages over the two leading techniques for studying patient tumors: creating immortal cell lines and transplanting human cancer cells into mice, says Alberto Bardelli of the Institute for Cancer Research and Treatment in Candiolo, Italy. Immortal cell lines often acquire new mutations as they adapt to growing in culture, and so they are a less accurate model of the cancer, Bardelli says. Tumors transplanted into immune-deficient mice, called xenotransplants, are more accurate, but they are expensive and hard to maintain. “Xenos are wonderful, but you can’t do large-scale [drug] screening on xenos,” he says.With the cancerous organoids, in contrast, the researchers were able to test more than 80 drugs and could measure how sensitive the mini-guts were to each compound. The mini-guts “fill a critical gap,” Bardelli says. “It’s very exciting.” Clevers says two clinical trials are already evaluating the usefulness of the cancerous mini-guts. The first tests how well an organoid created from a person newly diagnosed with colorectal cancer can predict the tumor’s response to treatments. A second will test whether the organoids can help identify drug combinations effective in people whose cancer has spread to multiple tissues. Click to view the privacy policy. Required fields are indicated by an asterisk (*) Emailcenter_img Country * Afghanistan Aland Islands Albania Algeria Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia, Plurinational State of Bonaire, Sint Eustatius and Saba Bosnia and Herzegovina Botswana Bouvet Island Brazil British Indian Ocean Territory Brunei Darussalam Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos (Keeling) Islands Colombia Comoros Congo Congo, the Democratic Republic of the Cook Islands Costa Rica Cote d’Ivoire Croatia Cuba Curaçao Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands (Malvinas) Faroe Islands Fiji Finland France French Guiana French Polynesia French Southern Territories Gabon Gambia Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Heard Island and McDonald Islands Holy See (Vatican City State) Honduras Hungary Iceland India Indonesia Iran, Islamic Republic of Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Korea, Democratic People’s Republic of Korea, Republic of Kuwait Kyrgyzstan Lao People’s Democratic Republic Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macao Macedonia, the former Yugoslav Republic of Madagascar Malawi Malaysia Maldives Mali Malta Martinique Mauritania Mauritius Mayotte Mexico Moldova, Republic of Monaco Mongolia Montenegro Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island Norway Oman Pakistan Palestine Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Qatar Reunion Romania Russian Federation Rwanda Saint Barthélemy Saint Helena, Ascension and Tristan da Cunha Saint Kitts and Nevis Saint Lucia Saint Martin (French part) Saint Pierre and Miquelon Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Sint Maarten (Dutch part) Slovakia Slovenia Solomon Islands Somalia South Africa South Georgia and the South Sandwich Islands South Sudan Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Swaziland Sweden Switzerland Syrian Arab Republic Taiwan Tajikistan Tanzania, United Republic of Thailand Timor-Leste Togo Tokelau Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States Uruguay Uzbekistan Vanuatu Venezuela, Bolivarian Republic of Vietnam Virgin Islands, British Wallis and Futuna Western Sahara Yemen Zambia Zimbabwe Sign up for our daily newsletter Get more great content like this delivered right to you! Countrylast_img read more